1. Home
  2. EDSA vs PRSO Comparison

EDSA vs PRSO Comparison

Compare EDSA & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • PRSO
  • Stock Information
  • Founded
  • EDSA 2015
  • PRSO 2008
  • Country
  • EDSA Canada
  • PRSO United States
  • Employees
  • EDSA N/A
  • PRSO N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • PRSO Semiconductors
  • Sector
  • EDSA Health Care
  • PRSO Technology
  • Exchange
  • EDSA Nasdaq
  • PRSO Nasdaq
  • Market Cap
  • EDSA 18.6M
  • PRSO 18.4M
  • IPO Year
  • EDSA N/A
  • PRSO 2001
  • Fundamental
  • Price
  • EDSA $2.66
  • PRSO $1.45
  • Analyst Decision
  • EDSA Strong Buy
  • PRSO Strong Buy
  • Analyst Count
  • EDSA 2
  • PRSO 1
  • Target Price
  • EDSA $13.00
  • PRSO $3.00
  • AVG Volume (30 Days)
  • EDSA 140.8K
  • PRSO 2.4M
  • Earning Date
  • EDSA 12-12-2025
  • PRSO 11-11-2025
  • Dividend Yield
  • EDSA N/A
  • PRSO N/A
  • EPS Growth
  • EDSA N/A
  • PRSO N/A
  • EPS
  • EDSA N/A
  • PRSO N/A
  • Revenue
  • EDSA N/A
  • PRSO $13,608,000.00
  • Revenue This Year
  • EDSA N/A
  • PRSO N/A
  • Revenue Next Year
  • EDSA N/A
  • PRSO $34.49
  • P/E Ratio
  • EDSA N/A
  • PRSO N/A
  • Revenue Growth
  • EDSA N/A
  • PRSO 1.80
  • 52 Week Low
  • EDSA $1.55
  • PRSO $0.52
  • 52 Week High
  • EDSA $4.49
  • PRSO $2.37
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 54.92
  • PRSO 49.93
  • Support Level
  • EDSA $2.42
  • PRSO $1.38
  • Resistance Level
  • EDSA $2.95
  • PRSO $2.37
  • Average True Range (ATR)
  • EDSA 0.21
  • PRSO 0.25
  • MACD
  • EDSA 0.01
  • PRSO -0.03
  • Stochastic Oscillator
  • EDSA 49.86
  • PRSO 23.62

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: